RecruitingNCT02139163
Epidemiological Study on Community Acquired Pneumonia
Sponsor
Capnetz Stiftung
Enrollment
20,000 participants
Start Date
Oct 1, 2002
Study Type
OBSERVATIONAL
Conditions
Summary
The main objective of this study is to investigate prevalence and risk factors for community-acquired pneumonia (CAP) and its interaction with comorbidities in an unselected group of adult patients receiving outpatient and inpatient care. In addition, information on HIV as a risk factor for CAP and on CAP in immunocompromised patients is collected.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- age ≥ 18
- infiltrate on chest X-ray
Exclusion Criteria2
- Hospitalization lasting longer than 48 hours prior to the diagnosis of the current pneumonia
- Newly diagnosed, active pulmonary tuberculosis within the last 2 months
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02139163
Related Trials
Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NCT0696631038 locations
Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia
NCT069968341 location
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT0584871364 locations
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
NCT0622928819 locations
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
NCT05722938147 locations